Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2021 Jun 24;16(6):e0253578. doi: 10.1371/journal.pone.0253578

SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis

David A Coil 1, Timothy Albertson 2, Shefali Banerjee 3, Greg Brennan 3, A J Campbell 4, Stuart H Cohen 5, Satya Dandekar 3, Samuel L Díaz-Muñoz 1,4, Jonathan A Eisen 1,3,6, Tracey Goldstein 7, Ivy R Jose 4, Maya Juarez 2, Brandt A Robinson 2, Stefan Rothenburg 3, Christian Sandrock 2, Ana M M Stoian 3, Daniel G Tompkins 2, Alexandre Tremeau-Bravard 7, Angela Haczku 2,*
Editor: Binod Kumar8
PMCID: PMC8224861  PMID: 34166421

Abstract

Rationale

There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear.

Objectives

We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis.

Methods

Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and staff congregation areas. qRT-PCR positive samples were investigated in Vero cell cultures for cytopathic effects and phylogenetically assessed by whole genome sequencing.

Measurements and main results

Improved cleaning and patient management practices between April and August 2020 were associated with a substantial reduction of SARS-CoV-2 qRT-PCR positivity (from 11% to 2%) in hospital surface samples. Even though we recovered near-complete genome sequences in some, none of the positive samples (11 of 224 total) caused cytopathic effects in cultured cells suggesting this nucleic acid was either not associated with intact virions, or they were present in insufficient numbers for infectivity. Phylogenetic analysis suggested that the SARS-CoV-2 genomes of the positive samples were derived from hospitalized patients. Genomic sequences isolated from qRT-PCR negative samples indicate a superior sensitivity of viral detection by sequencing.

Conclusions

This study confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces contains infectious virus, disputing the importance of fomites in COVID-19 transmission. Ours is the first report on recovering near-complete SARS-CoV-2 genome sequences directly from environmental surface swabs.

Introduction

There is a paucity of data regarding survival and infectivity of the SARS-CoV-2 virus on surfaces in closed environments, although some data are available for other coronaviruses [1, 2]. Early in the pandemic, testing of artificially generated aerosols on copper, stainless steel, cardboard, and plastic surfaces found a rapid decay of viral viability within a few days [3]. Another study examining survival on PPE showed that the virus decayed rapidly on cotton but survived for up to 21 days on some other surface material [4]. More recent evaluation of a variety of surfaces showed that infectious virions could survive for up to 28 days in laboratory conditions including high titer virus and in the dark [5]. However, it is unclear in all of these cases how this relates to virus survival and the potential for its transmission outside the laboratory. A study of high-touch surfaces in a community setting attempted to estimate transmission risk, but there are still too many unknowns to do this with any confidence [6]. It is known that SARS-CoV-2 can survive on skin for about nine hours and may allow or extend viral survival on surfaces following contact [7].

A key complication in studies of SARS-CoV-2 environmental viability relates to how long the viral RNA can be detected on surfaces. A large number of studies have used qRT-PCR to detect SARS-CoV-2 viral RNA indoors [8–20] reviewed in [21] and found that the virus was detectable up to several weeks after it was presumably deposited [22]. The amount of viral RNA detected seems to be inversely correlated with cleaning protocols [23]. This probably explains otherwise surprising results such as the lack of viral RNA detected in an oncology ward housing patients with COVID-19 [24], or the very low probability of detection in an ICU [25]. Several studies detected SARS-CoV-2 RNA in these environments but were unable to culture infectious SARS-CoV-2 virions [26–28]. However, viable SARS-CoV-2 was successfully cultured and sequenced from the air of the hospital room with a COVID-19 patient using a water vapor condensation method [29].

In this study, we assessed environmental contamination with SARS-CoV-2 in a hospital setting by both qRT-PCR and a viral culture assay. We examined surfaces, and also sampled HVAC filters since these have been previously shown to contain SARS-CoV-2 in healthcare settings [30, 31] and in homes [22]. In addition, we sequenced partial and complete genomes from surfaces and compared them phylogenetically to identify the source of the virus.

Materials and methods

Swab sample collection at the UC Davis Medical Center (UCDMC)

UCDMC is a 625-bed academic medical center in Northern California. While there are multiple ICUs and medical floors, during the first 6 months of the pandemic, most patients with active COVID-19 were hospitalized in 3 intensive care units (ICU) and 2 medical wards. Both the ICU and medical wards have the ability to place individual rooms as well as the entire ward under negative pressure, and that was the case during the study. Samples were collected using standard Puritan cotton-tipped swabs with plastic handles and placed into Trizol as described below. The first set of samples was collected in April 2020, and the second set between late July/early August 2020. Clinical staff swabbed an approximately 10cm x 10 cm area for several seconds, as if trying to clean it with a scrubbing motion and rotating the swab.

Heating, Ventilation, and Air Conditioning (HVAC) swab collection

Swabs were moistened in saline, brushed across the air filters, and then placed into 500 ul of Trizol(R). For safety reasons, the air pressure in the HVAC system was temporarily reduced during sampling. Sampling took place on the filters which protect the evaporator coils from dust, meaning that the sampled dust was unfiltered directly from the hospital floor. Samples were collected both from the floor with a number of COVID-19 patients, as well as from another floor with no known COVID-19 patients. All samples were frozen at -80 °C until processing.

Surface sampling

During the first collection, swabs were pre-moistened in sterile saline and then placed into 500 uL Trizol(R); during the second round, swabs were either pre-moistened with Trizol(R) or viral transport media (VTM, Innovative Research™) and then placed into their respective individual containers after sample collection. All samples were stored frozen at -80 °C until processing.

Surface sampling (for viability testing)

For viability testing, a pair of swabs were held together for the swabbing. One was placed in Trizol for qRT-PCR (as described above) and the other into VTM. All samples were stored frozen at -80 °C until processing.

qRT-PCR

RNA extraction from swabs was performed using the Zymo Research Direct-zol-96RNA kit (#R2054). Briefly, 500 ul of pure ethanol was added to the 500 ul of Trizol+swab. The mixture was transferred to a I-96 plate extraction performed according to the manufacturer instructions. RNA was eluted in 25 ul water and cDNA was made using the SuperScriptIII ThermoFisher kit (#18080051). SARS-CoV-2 screening was performed by qRT-PCR using Taqman Universal Master Mix II+UNG (ThermoFisher #4440038). Primers and probes and cycling conditions to detect segments of the N and RdRp genes were performed following the CDC (https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html) and Corman et al. protocols [32]. qRT-PCR was run for 45 cycles and any positive signal was reported.

Vero cell culture and SARS-CoV-2 infection studies

Vero E6 cells (ATCC #CRL-1586) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 IU/ml of penicillin-streptomycin (Pen-Strep; Gibco). The mNeonGreen SARS-CoV-2 (icSARS-CoV-2-mNG) virus [33] was kindly provided by the UTMB World Reference Center for Emerging Viruses and Arboviruses and Dr. Scott Weaver, and was propagated and titered in Vero E6 cells. All swab samples and positive controls were diluted in D10-CoV medium consisting of DMEM supplemented with 10% FBS, 100 IU/ml Pen-Strep, 250 μg/ml Amphotericin B (Gibco) and 250 μg/ml Gentamicin (Quality Biologicals).

Six-well plates of Vero E6 cells (~60% confluent) were infected with either 300 uL of the viral transport medium from qRT-PCR positive environmental swab samples diluted 1:1 in D10-CoV medium, or 300 μL of mNeonGreen SARS-CoV-2 (icSARS-CoV-2-mNG) 10-fold serially diluted in D10-CoV medium to infect wells with 105 PFU to 100 PFU per well. Following 1h incubation at 37 °C, rocking plates every 15 minutes, the cells were replenished with fresh D10-CoV medium and incubated at 37 °C + 5% CO2 for five days. A mock-treated control consisting of cells only maintained in D10-CoV medium was included in the assay and treated identically. All samples were tested in duplicate. Two and five days post-infection, the cells were assessed microscopically for any visible cytopathic effect. Five days post infection, 2 mL of cell culture supernatant was collected from each well and mixed with 6 mL of Trizol LS reagent (Ambion). Cell lysates were harvested by adding 1 mL of Trizol LS reagent to the cell monolayer. All Trizol-treated samples were used for RNA extraction and qRT-PCR.

SARS-CoV-2 viral genome sequencing

We prepared RNA extractions for Oxford Nanopore (ONT) MinION sequencing of SARS-CoV-2 viral genomes. We made modifications to the ARTIC Network Protocol (v2) [34], to optimize sequencing of environmental samples. Our complete protocol is available online https://www.protocols.io/view/ncov-2019-environmental-sample-sequencing-protocol-brnbm5an. In brief: we conducted random hexamer primed reverse transcription and amplified cDNA using v3 primers, which tile the entire viral genome (save for non-coding regions at the genome ends) with overlapping 400 bp fragments. We concentrated PCR products using the Zymo Select-a-Size DNA Clean & Concentrator Kit (Zymo Research, Irvine CA), ligated barcodes using the Oxford Nanopore Native Barcoding kit, and ligated sequencing adaptors. Samples were run on ONT R9.4 or R10.3 flow cells. We followed the ARTIC Network bioinformatics SOP, which in brief involved high accuracy basecalling and demultiplexing using ONT Guppy, mapping reads to the Wuhan-Hu-1 (accession MN908947) reference, polishing with Nanopolish, and consensus generation (code for analysis available https://github.com/sociovirology/sars_cov2_environmental_seq).

Results and discussion

Improved cleaning protocol and patient management was associated with decreased recovery of SARS-CoV-2 RNA from hospital surface samples

During the first wave of COVID-19 (March-April, 2020) the role of fomites in transmission was controversial and studies providing supporting evidence for it were lacking. Some of our hospital personnel also became ill with COVD-19 at that time. To investigate whether the infection clusters among health care workers were associated with SARS-CoV-2 contaminated areas, we collected 56 swabs in April 2020, from a variety of frequently used locations. Six of these samples (11%) tested positive for SARS-CoV-2 by qRT-PCR for the viral N1 and N2 genes (Fig 1). While the positive locations were in the proximity of hospitalized COVID-19 patients, none of these areas were related to where the hospital personnel cluster infections were suspected to originate from.

Fig 1. Representative ward room sampled by swabs for SARS-CoV-2 at the UCDMC.

Fig 1

Open in a new tab

Positive samples are shown in red, negative samples in green. Each dot represents a single swab.

During a three-month period between April and August 2020, important changes took place to improve cleaning protocols with a change in the frequency/duration/composition of cleaning material in the hospital. In addition to the cleaning protocol changes, improved patient management of respiratory secretions took place. This included earlier intubation, rapid sequence ventilation, and changes in the management of high O2 flow nasal cannulas. To investigate whether changes in cleaning practices and patient management impacted the outcomes compared to our earlier findings, we performed a follow-up study by collecting an additional 168 swabs. Out of these, only five tested positive for SARS-CoV-2 by qRT-PCR (S1 and S2 Tables). None of the HVAC samples were positive by qRT-PCR.

Thus, our results show a substantial decrease in positive samples from 11% to 2% between April and August. This trend is particularly significant in the light that in mid-August, 2020, a second surge of COVID-19 cases were admitted, substantially increasing the number of patients in the hospital (Fig 2).

Fig 2. SARS-CoV-2 positive patients at UCDMC during the first and the second wave of COVID-19.

Fig 2

Open in a new tab

Weekly totals of COVID-19 patients, and the cumulative total number from early March until mid-August, 2020. The blue arrows indicate the sampling dates.

We propose that together, the improved cleaning protocols and patient management practices likely contributed to decreased presence of aerosolized (and deposited) virions in the rooms where COVID-19 patients were cared for. It was still unclear however, whether the recovered viral RNA from the samples collected from hospital surfaces could be a feasible source of infection.

Hospital surface SARS-CoV-2 RNA did not exhibit infectious nature in a Vero cell culture model in vitro

To investigate whether the SARS-CoV-2 qRT-PCR positivity in hospital surface samples was associated with potential infectivity, a total of five swabs (identified as positive by qRT-PCR) were tested. We used an in vitro infection assay to detect the presence of infectious virus particles. Each of the wells of Vero E6 cells incubated with individual swab samples appeared identical to the mock-infected cells and showed no signs of cytopathic effect (CPE) by microscopy for up to five days post-infection (dpi) (Fig 3). This lack of CPE in swab-inoculated wells was consistent in two biologically independent infection assays in all tested samples. In contrast, positive control samples infected with 10-fold serial-dilutions from 105 to 1 PFU of mNeonGreen SARS-CoV-2 showed notable CPE and mNeonGreen expression throughout the course of infection, even in wells infected with only 1 PFU (Fig 3). Therefore, the lack of CPE in the environmental swab samples indicated the absence of infectious virus particles or samples with a viral load below the detection limit for viral culture.

Fig 3. Micrographs of Vero E6 cells five days after inoculation.

Fig 3

Open in a new tab

Cells were either mock-infected (upper left), inoculated with swab samples (representative of all five tested samples, upper right), or infected with one PFU of mNeonGreen SARS-CoV-2 (phase contrast, lower left; mNeonGreen lower right).

To confirm this result, supernatant and cell lysates from the swab and positive control inoculated Vero E6 cells were collected five dpi from each independent experiment. Total RNA from each sample was analyzed by qRT-PCR assay in duplicate, and while no signal was observed with the N1 primer set, a low signal (CT 28, 37) was detected in two of the samples with the N2 primer set. A repeat of this experiment in triplicate for each sample only yielded low signal in a single reaction (CT 37). In combination with the lack of viral infectivity in cell culture assays, our data suggest that the signal most likely represented relic RNA from the original swab and not due to the replication of viral particles in culture.

Viral genome sequencing

In order to determine the genome sequences from the isolated samples, we generated a total of 17,567,849 reads across five separate MinION sequencing runs (S3 Table), of which 6,670,616 were used for mapping after demultiplexing and quality control. The negative control in Run 4 yielded reads that mapped to the reference genome, therefore samples were re-sequenced in Run 5. Negative controls in Runs 1–3 and 5 had no reads mapping to the reference genome. At least one positive control (included in Runs 4 and 5), per run produced reads that mapped to the reference genome (details in GitHub repository https://github.com/sociovirology/sars_cov2_environmental_seq).

The genome coverage obtained from samples was assigned to three groups: >15% (n = 61), 20–40% (n = 5), >75% (n = 5). The percent of the genome covered at a 5X depth quickly declined as a function of increasing mean Ct values (Fig 4). There was a notable threshold of Ct ~ 38, above which no sample achieved >10% genome completeness.

Fig 4. Environmental swabs with Ct values below 38 yielded enough sequence reads to cover a substantial portion of the SARS-CoV-2 genome.

Fig 4

Open in a new tab

The percent of the SARS-CoV-2 reference genome (isolate Wuhan-Hu-1) covered at ≥ 5X decreased steeply as a function of the mean Ct value (using CDC N1, N2, and Berlin RdRP primers). The colored points represent individual swab samples, some of which were re-run in independent sequencing runs.

Whole-genome PCR and sequencing yields more effective detection of SARS-CoV-2 than qRT-PCR

While there was a steep drop-off in achieving a full genome sequence with increasing Ct values, the sequencing protocol was able to detect SARS-CoV-2 in samples with undetermined Ct scores by PCR, with an average of 6.27% coverage (range: 2.19–14.78%). Using a sequencing cutoff of >2% genome coverage, sequences of SARS-CoV-2 were amplified in 15 samples that had no detectable Ct by PCR, whereas five samples that did not have a detectable Ct were not amplified by sequencing (at >2% coverage). This uncoupling of detection by qRT-PCR vs sequencing is likely due to the fact that qRT-PCR targets only a small portion of the genome and sequencing primers cover the entire genome (e.g. [35]). Furthemore, environmental samples in particular may have been degraded or diluted, affecting the genomic RNA available for reverse transcription, as observed in multiple studies of environmental samples [36–38].

Generation of near-complete genomes from environmental samples

We recovered two near-complete genomes from two different patient rooms, D14 and T7 Blue. These samples were collected from two surfaces, the floor and a soiled linens basket lid. Genome coverage and Ct values for D14 were 99.26% (Mean Ct = 36.49) and T7 Blue 91.75% (Mean Ct = 36.89), both with a depth cutoff of 5X to call a base. The sample from room D14 had an average depth of 371.21 ± 171.30 reads (mean ± SD). The sample from room T7 had an average depth of 377.14 ± 185.03.

Effect of protocol modifications for environmental sample sequencing

The ARTIC protocol was modified in two major ways to accommodate the lower sample concentration in environmental samples compared to clinical samples: concentration and cleaning of PCR products and making duplicate barcoding reactions. Concentration of PCR products increased the genome coverage from 96.31% to 99.02% (sample from room D14) and from 76.08% to 91.75% (sample from room T7 Blue), compared to the standard ARTIC protocol. Duplicate barcoding reactions only marginally increased genome coverage in the sample from room D14 from 99.02% to 99.26%.

Recovered genome sequences are from clade 19B may have originated from a single patient, or from multiple patients infected with similar viruses

To compare the near-complete genome sequences generated, we conducted phylogenetic analyses. We first determined that the pairwise identity between these two genomes was 93.8%, with several polymorphisms present. We conducted a phylogenetic analysis using NextStrain [39] to compare the sequences with other viruses detected through local subsampling in California and Sacramento County specifically. Both sequences were placed in clade 19B (Fig 5a), which were the first sequenced variants that circulated (along with 19A) in Asia early in the epidemic [40]. We included all publicly available samples sequenced from UCDMC in the phylogeny (Fig 5b). Both sequences clustered with UCDMC sample USA/CA-CZB-1145/2020, and notably these three samples clustered in an entirely different clade than the rest of the UCDMC samples, which were in clade 20C that arose in Europe. Thus, it appears likely these samples were derived from a single patient (or from multiple patients infected with similar viruses) from which USA/CA-CZB-1145/2020 originated.

Fig 5. Phylogenetic comparison of the SARS-CoV-2 sequences obtained from environmental swabs at UCDMC.

Fig 5

Open in a new tab

A. Near-complete genomes obtained from environmental samples clustered in clade 19B. The phylogenetic tree was generated using the NextStrain protocol, and compares sequences to others amplified in Sacramento County in California. B. Environmental genome sequences may have originated from a single patient, or from multiple patients infected with similar viruses. All publicly available patient samples originating from UC Davis are shown as blue points at the tips of the phylogeny. Note that most sequences from UC Davis in this time period are members of the 20C clade, as opposed to the environmental sequences that are members of clade 19B together with sample USA/CA-CZB-1145/2020.

Conclusions

Eleven percent of samples collected at the UC Davis Medical Center in April 2020 were positive for SARS-CoV-2 whereas a larger follow-up experiment in August found only 2% of swabs positive, which is likely due to improved cleaning protocols and improved management of patient respiratory secretions. Near-complete genome sequences were amplified from two surfaces, suggesting the presence of viral genomes. However, in agreement with numerous other studies, no infectious virus was detectable from surfaces. Taken together, these findings suggest that while the virus on surfaces doesn’t appear to be infectious, there is still a need for other mitigation measures to minimize transmission risk. Genome sequences from the positive samples at the first sampling point suggest that the environmental contamination was linked to a single lineage of virus, most likely from a single patient or from multiple patients with closely related infections. While interpreting our data, we need to take in consideration that this study was conducted in just one medical center at a specific humidity, temperature, UV light, ventilation, occupancy, activity level and environmental context and at the time when the different variants of SARS-Co-V-2 that we see currently were not known. Importantly, we show here that viral sequences could be amplified from samples that were negative by qRT-PCR, highlighting the superior sensitivity of this technique and raising its potential suitability to identify SARS-CoV-2 variants from environmental samples.

Supporting information

S1 Table. Locations of samples positive for SARS-CoV-2 by qRT-PCR.

“U” is Undetermined (at 45 cycles of qRT-PCR). All patient rooms were occupied by known COVID-19 cases. The 1st wave was in the spring of 2020, and the second was in late summer 2020.

(DOCX)

Click here for additional data file. (14KB, docx)
S2 Table. Locations and qRT-PCR results for all samples collected.

Undetermined is at 45 cycles of qRT-PCR.

(DOCX)

Click here for additional data file. (40.5KB, docx)
S3 Table. Sequencing information for 5 MinION runs, detailing number of raw reads generated and the amount retained at each step of the bioinformatics pipeline.

(DOCX)

Click here for additional data file. (13.5KB, docx)

Acknowledgments

The authors would like to thank Samantha Levy for help with transcribing data and collecting references, and the UC Davis Pulmonary and Critical Care Clinical Research Unit staff for collecting the clinical samples.

Data Availability

All relevant data are uploaded to GitHub (https://github.com/sociovirology/sars_cov2_environmental_seq).

Funding Statement

Funding for this work was provided by a UC Davis CRAFT Award (JAE and DAC) and The Chester Robbins Endowment (AH).

References

  • 1.Aboubakr HA, Sharafeldin TA, Goyal SM. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: A review. Transbound Emerg Dis 2020; doi: 10.1111/tbed.13707 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bilal M, Munir H, Nazir MS, Iqbal HMN. Persistence, transmission, and infectivity of SARS-CoV-2 in inanimate environments. Case Studies in Chemical and Environmental Engineering 2020;2:100047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020;382:1564–1567. doi: 10.1056/NEJMc2004973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kasloff SB, Strong JE, Funk D, Cutts TA. Stability of SARS-CoV-2 on Critical Personal Protective Equipment. medRxiv 2020; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Riddell S, Goldie S, Hill A, Eagles D, Drew TW. The effect of temperature on persistence of SARS-CoV-2 on common surfaces. Virol J 2020;17:145. doi: 10.1186/s12985-020-01418-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Harvey AP, Fuhrmeister ER, Cantrell M, Pitol AK, Swarthout JM, Powers JE, et al. Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting. medRxiv 2020; doi: 10.1101/2020.10.27.20220905 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hirose R, Ikegaya H, Naito Y, Watanabe N, Yoshida T, Bandou R, et al. Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19. Clin Infect Dis 2020; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chia PY, Coleman KK, Tan YK, Ong SWX, Gum M, Lau SK, et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Commun 2020;11:2800. doi: 10.1038/s41467-020-16670-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Santarpia JL, Rivera DN, Herrera VL, Morwitzer MJ, Creager HM, Santarpia GW, et al. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep 2020;10:12732. doi: 10.1038/s41598-020-69286-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Peyrony O, Ellouze S, Fontaine J-P, Thegat-Le Cam M, Salmona M, Feghoul L, et al. Surfaces and equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the emergency department at a university hospital. Int J Hyg Environ Health 2020;230:113600. doi: 10.1016/j.ijheh.2020.113600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ye G, Lin H, Chen S, Wang S, Zeng Z, Wang W, et al. Environmental contamination of SARS-CoV-2 in healthcare premises. J Infect 2020;81:e1–e5. doi: 10.1016/j.jinf.2020.04.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhou L, Yao M, Zhang X, Hu B, Li X, Chen H, et al. Breath-, air- and surface-borne SARS-CoV-2 in hospitals. J Aerosol Sci 2020;105693. doi: 10.1016/j.jaerosci.2020.105693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Nakamura K, Morioka S, Kutsuna S, Iida S, Suzuki T, Kinoshita N, et al. Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infection Prevention in Practice 2020;2:100098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mouchtouri VA, Koureas M, Kyritsi M, Vontas A, Kourentis L, Sapounas S, et al. Environmental contamination of SARS-CoV-2 on surfaces, air-conditioner and ventilation systems. Int J Hyg Environ Health 2020;230:113599. doi: 10.1016/j.ijheh.2020.113599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lei H, Ye F, Liu X, Huang Z, Ling S, Jiang Z, et al. SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients. Influenza Other Respi Viruses 2020;14:688–699. doi: 10.1111/irv.12783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wu S, Wang Y, Jin X, Tian J, Liu J, Mao Y. Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019. Am J Infect Control 2020;48:910–914. doi: 10.1016/j.ajic.2020.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hu X, Xing Y, Ni W, Zhang F, Lu S, Wang Z, et al. Environmental contamination by SARS-CoV-2 of an imported case during incubation period. Sci Total Environ 2020;742:140620. doi: 10.1016/j.scitotenv.2020.140620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA 2020;323:1610–1612. doi: 10.1001/jama.2020.3227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Declementi M, Godono A, Mansour I, Milanesio N, Garzaro G, Clari M, et al. Assessment of air and surfaces contamination in a COVID-19 non-Intensive Care Unit. Med Lav 2020;111:372–378. doi: 10.23749/mdl.v111i5.9991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wei L, Huang W, Lu X, Wang Y, Cheng L, Deng R, et al. Contamination of SARS-CoV-2 in patient surroundings and on personal protective equipment in a non-ICU isolation ward for COVID-19 patients with prolonged PCR positive status. Antimicrob Resist Infect Control 2020;9:167. doi: 10.1186/s13756-020-00839-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med 2021;174:69–79. doi: 10.7326/M20-5008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Maestre JP, Jarma D, Yu C, Siegel J, Horner S, Kinney KA. Distribution of SARS-CoV-2 RNA Signal in a Home with COVID-19 Positive Occupants. medRxiv 2020;at <https://www.medrxiv.org/content/10.1101/2020.11.30.20234393v1.abstract>. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Colaneri M, Seminari E, Piralla A, Zuccaro V, Filippo AD, Baldanti F, et al. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy. J Hosp Infect 2020; doi: 10.1016/j.jhin.2020.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jan I, Chen K, Sayan M, Uprety P, Laumbach RJ, Ennis RD, et al. Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic. JAMA Oncol 2020;6:1632–1634. doi: 10.1001/jamaoncol.2020.3552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Li YH, Fan YZ, Jiang L, Wang HB. Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients. Epidemiol Infect 2020;148:e154. doi: 10.1017/S0950268820001570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Colaneri M, Seminari E, Novati S, Asperges E, Biscarini S, Piralla A, et al. Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit. Clin Microbiol Infect 2020;26:1094.e1–1094.e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ben-Shmuel A, Brosh-Nissimov T, Glinert I, Bar-David E, Sittner A, Poni R, et al. Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities. Clin Microbiol Infect 2020;26:1658–1662. doi: 10.1016/j.cmi.2020.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Parker CW, Singh N, Tighe S, Blachowicz A, Wood JM, Seuylemezian A, et al. End-to-End Protocol for the Detection of SARS-CoV-2 from Built Environments. mSystems 2020;5. doi: 10.1128/mSystems.00771-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lednicky JA, Lauzardo M, Fan ZH, Jutla A, Tilly TB, Gangwar M, et al. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int J Infect Dis 2020;100:476–482. doi: 10.1016/j.ijid.2020.09.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Horve PF, Dietz L, Fretz M, Constant DA, Wilkes A, Townes JM, et al. Identification of SARS-CoV-2 RNA in Healthcare Heating, Ventilation, and Air Conditioning Units. medRxiv 2020; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nissen K, Krambrich J, Akaberi D, Hoffman T, Ling J, Lundkvist Å, et al. Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards. Sci Rep 2020;10:19589. doi: 10.1038/s41598-020-76442-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.3.2000045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020;27: 841–848.e3. doi: 10.1016/j.chom.2020.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Tyson JR, James P, Stoddart D, Sparks N, Wickenhagen A, Hall G, et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv 2020; doi: 10.1101/2020.09.04.283077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.McCuen MM, Pitesky ME, Buler JJ, Acosta S, Wilcox AH, Bond RF, et al. A comparison of amplification methods to detect Avian Influenza viruses in California wetlands targeted via remote sensing of waterfowl. Transbound Emerg Dis 2020; doi: 10.1111/tbed.13612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Izquierdo Lara RW, Elsinga G, Heijnen L, Oude Munnink BB, Schapendonk CME, Nieuwenhuijse D, et al. Monitoring SARS-CoV-2 circulation and diversity through community wastewater sequencing. bioRxiv 2020; doi: 10.1101/2020.09.21.20198838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Crits-Christoph A, Kantor RS, Olm MR, Whitney ON, Al-Shayeb B, Lou YC, et al. Genome Sequencing of Sewage Detects Regionally Prevalent SARS-CoV-2 Variants. MBio 2021;12. doi: 10.1128/mBio.02703-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fontenele RS, Kraberger S, Hadfield J, Driver EM, Bowes D, Holland LA, et al. High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants. medRxiv 2021; doi: 10.1101/2021.01.22.21250320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 2018;34:4121–4123. doi: 10.1093/bioinformatics/bty407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rambaut A, Holmes EC, Hill V, O’Toole Á, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology. doi: 10.1101/2020.04.17.046086 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Binod Kumar

17 May 2021

PONE-D-21-11199

SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis

PLOS ONE

Dear Dr. Coil,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the minor points raised during the review process.

Please submit your revised manuscript by Jun 28 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Binod Kumar, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The Manuscript by Coil et al deals with an important issue in the current pandemic situation whether different hospital surfaces possess contagious and infective SARS-Cov2 viral particles. The study clearly showed that although viral genome is found in many surfaces in hospital setting but they are not contagious at all. The authors also identified that the important issue related to proper cleaning management helps to reduce RT-PCR positivity in different hospital surfaces. Using whole genome sequencing authors recovered a near-complete viral genome from various surface swabs.

Overall the work is impressive with few minor concerns listed below:

1. While constructing the phylogenetic tree, the authors claim that the samples where near-complete genome was recovered by sequencing were derived from single patient. This might also be possible that multiple patients were infected with similar virus since at the time of study only few variants/mutants were in USA/UCDMC. This statement needs to be corrected both in results section (line – 289) and conclusion (line 301-302) section. That might be more correct scientific way to discuss the issue.

2. There are couple of reports in others study also showed that there is minimal chance of viral infectivity from different surfaces. There are also several reports suggest that cleaning reduces viral particles on surfaces. Thus this manuscript lacks novelty in this perspective.

3. The conclusion section needs to be elaborated with reference to previous findings in this context and a brief necessary discussion will help readers to better understand the importance of this work.

4. Figure Legends section – Figure 5 heading needs to be bold character.

Reviewer #2: The manuscript by Coil et. al. aims to study the surface swab of SARS-COV2- RNA and determine its applicability in sequencing studies. Overall, this is a well written manuscript which looks at an extremely relevant topic and will add to the existing knowledge about the COVID-19 pandemic. Furthermore, this study has the potential to be informative in cases where a new cleaning method is being tested in places such as long-term senior care facilities as we all to evaluate the effectiveness of different control measures. Although the study provides evidence of low likelihood that hospital surface samples (with proper cleaning method in place) contains low likelihood of active transmission the article can include in the conclusion that the results should not encourage to replace the existing public health measures of keeping good hygiene and physical distancing to prevent transmission. Additionally, the study should mention in the discussion that the conclusion should be considered keeping the following in mind that it was conducted in just one medical center at a specific humidity, temperature, UV light, ventilation, occupancy, activity level and environmental context and importantly at a time when the different variants of SARS-COV2 that we see currently were not known. Please also mention the for which gene the RT-PCR were conducted in the main text. Overall, this is a relevant and well written manuscript.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Rupkatha Mukhopadhyay

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Binod Kumar

9 Jun 2021

SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis

PONE-D-21-11199R1

Dear Dr. Coil,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Binod Kumar, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript by Coil et al., addresses all the points that were raised and their reviewed version of manuscript improved substantially. Overall the study is important for the identification of the source of contagion of SARS-CoV at the hospital setting in the current pandemic scenario.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Rupkatha Mukhopadhyay

Reviewer #2: No

Acceptance letter

Binod Kumar

14 Jun 2021

PONE-D-21-11199R1

SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis

Dear Dr. Coil:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Binod Kumar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Locations of samples positive for SARS-CoV-2 by qRT-PCR.

    “U” is Undetermined (at 45 cycles of qRT-PCR). All patient rooms were occupied by known COVID-19 cases. The 1st wave was in the spring of 2020, and the second was in late summer 2020.

    (DOCX)

    Click here for additional data file. (14KB, docx)
    S2 Table. Locations and qRT-PCR results for all samples collected.

    Undetermined is at 45 cycles of qRT-PCR.

    (DOCX)

    Click here for additional data file. (40.5KB, docx)
    S3 Table. Sequencing information for 5 MinION runs, detailing number of raw reads generated and the amount retained at each step of the bioinformatics pipeline.

    (DOCX)

    Click here for additional data file. (13.5KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    Click here for additional data file. (14.5KB, docx)

    Data Availability Statement

    All relevant data are uploaded to GitHub (https://github.com/sociovirology/sars_cov2_environmental_seq).

    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES